Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Andrew Damokosh"'
Autor:
Diane R, Gold, George, Allen, Andrew, Damokosh, Paulina, Serrano, Carl, Hayes, Margarita, Castiilejos
Publikováno v:
Journal of the AirWaste Management Association (1995). 46(4)
To evaluate methods of reducing exposure of school children in southwest Mexico City to ambient ozone, outdoor ozone levels were compared to indoor levels under three distinct classroom conditions: windows/doors open, air cleaner off; windows/doors c
Autor:
Namiki Izumi, Yoshiiku Kawakami, Kenji Ikeda, Kazuhide Yamamoto, Kazuhiko Koike, Norifumi Kawada, Kazuaki Chayama, Yoshiyasu Karino, Yoshiyuki Suzuki, Eric Hughes, Timothy Eley, Tetsuo Takehara, Hiroki Ishikawa, Akio Ido, Hidetaka Miyagoshi, Andrew Damokosh, Joji Toyota, Koichi Takaguchi, Fiona McPhee, Hiromitsu Kumada, Michio Sata
Publikováno v:
Hepatology (Baltimore, Md.)
All-oral combinations of direct-acting antivirals may improve efficacy and safety outcomes for patients with hepatitis C virus (HCV) infection, particularly those who are poor candidates for current interferon/ribavirin-based regimens. In this open-l
Autor:
Lajos, Pusztai, Mark, Ayers, James, Stec, Edward, Clark, Kenneth, Hess, David, Stivers, Andrew, Damokosh, Nour, Sneige, Thomas A, Buchholz, Francisco J, Esteva, Banu, Arun, Massimo, Cristofanilli, Daniel, Booser, Marguerite, Rosales, Vicente, Valero, Constantine, Adams, Gabriel N, Hortobagyi, W Fraser, Symmans
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 9(7)
The purpose of this study was to determine whether comprehensive transcriptional profiles (TPs) can be obtained from single-passage fine-needle aspirations (FNAs) of breast cancer and to explore whether profiles capture routine clinicopathological pa
Autor:
Nathalie Pochet, Frank De Smet, Sebastian Hoersch, Andrew Damokosh, Toon Van Gorp, Lynn C. Hartmann, Bart De Moor, Dirk Timmerman, Ignace Vergote
Publikováno v:
Clinical Cancer Research. 11:7958-7959
To the Editor: With great interest, we read the article by Hartmann et al. ([1][1]) investigating whether it is possible to apply gene expression patterns in order to discriminate between ovarian tumors with early and late relapse after platinum-pacl
Publikováno v:
Blood. 116:4938-4938
Abstract 4938 Introduction: Dasatinib 100 mg once daily (QD) has superior efficacy compared with imatinib in patients with newly diagnosed CML-CP, as demonstrated by a randomized phase 3 trial in this setting (CA180-056/DASISION; Kantarjian et al, N
Autor:
Ted Szatrowski, Andrew Damokosh, Hagop M. Kantarjian, Erkut Bahceci, Jorge E. Cortes, Ali M Al-Ameri, Gautam Borthakur
Publikováno v:
Blood. 114:1120-1120
Abstract 1120 Poster Board I-142 BACKGROUND Dasatinib is a tyrosine kinase inhibitor that can achieve rapid and durable hematological, cytogenetic, and molecular responses in patients with CML-CP after resistance or intolerance to imatinib. Three yea
Autor:
J. VanTornout, Dong-Kee Kim, Nina Shah, Oliver G. Ottmann, Yeow-Tee Goh, Andrew Damokosh, Hagop M. Kantarjian, Ricardo Pasquini
Publikováno v:
Blood. 108:746-746
Dasatinib (SPRYCEL®, formerly BMS-354825), an oral multi-targeted kinase inhibitor of BCR-ABL and SRC kinases, has been shown to be safe and effective at 70 mg BID in pts with CML and Ph(+) ALL who are resistant or intolerant to im. Based on a previ